Price $1.00 |
Market Cap
38.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.43
|
P/S
1.89
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-16.1K
|
FCF
-0.5
|
|
Op. Margin
-79.30%
|
Net Margin
-80.00%
|
ROE
-75.50%
|
ROI
-43.00%
|
|
ROA
-37.80%
|
EPS Growth
59.60%
|
Current Ratio
5.4
|
Debt/Equity
73.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $6.18 | - | - | 76.8M | Strong Buy |
| Biomerica, Inc. (BMRA) | $3.25 | - | - | 33.8M | Strong Buy |
| Lannett Company, Inc. (LCI) | $6.77 | - | - | 258.4M | Strong Buy |
| American Renal Associates Hold (ARA) | $7.14 | - | - | 240.3M | Strong Buy |
| TearLab Corp (TEAR) | $0.07 | - | - | 900K | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
